Limited infiltration of exogenous dendritic cells and naive T cells restricts immune responses in peripheral lymph nodes

Journal of Immunology

Volumn 176, Issue 8, 2006, Pages 4535-4542

  Mullins, David W ^a   Engelhard, Victor H ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN PRESENTING CELL; ARTICLE; CANCER CONTROL; CANCER IMMUNOTHERAPY; CD8+ T LYMPHOCYTE; CELL INFILTRATION; CONTROLLED STUDY; DENDRITIC CELL; IMMUNE RESPONSE; LYMPH NODE; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 33645775260     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.176.8.4535     Document Type: Article

References (39)

1. Zitvogel, L., J. I. Mayordomo, T. Tjandrawn, A. B. DeLeo, M. R. Clarke, M. T. Lotze, and W. J. Storkus. 1995. Therapy of murine tumors with peptide-pulsed dendritic cells: dependence of T cells, B7 costimulation, and T helper cell 1-associated cytokines. J. Exp. Med. 183: 87-97.
2. + T cell precursors. J. Immunol. 172: 4215-4224.
3. Paglia, P., C. Chiodoni, M. Rodolfo, and M. P. Colombo. 1996. Murine dendritic cells loaded in vitro with soluble protein prime cytotoxic T lymphocytes against tumor antigen in vivo. J. Exp. Med. 183: 317-322.
4. Mullins, D. W., T. N. Bullock, T. A. Colella, V. V. Robila, and V. H. Engelhard. 2001. Immune responses to the HLA-A*0201-restricted epitopes of tyrosinase and glycoprotein 100 enable control of melanoma outgrowth in HLA-A*0201-transgenic mice. J. Immunol. 167: 4853-4860.
5. Nestle, F. O., S. Alijagic, M. Gilliet, Y. Sun, S. Grabbe, R. Dummer, G. Burg, and D. Schadendorf. 1998. Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells. Nat. Med. 4: 328-332.
6. Thurner, B., I. Haendle, C. Roder, D. Dieckmann, P. Keikavoussi, H. Jonuleit, A. Bender, C. Maczek, D. Schreiner, D. P. von den, et al. 1999. Vaccination with mage-3A1 peptide-pulsed mature, monocyte-derived dendritic cells expands specific cytotoxic T cells and induces regression of some metastases in advanced stage IV melanoma. J. Exp. Med. 190: 1669-1678.
7. Dallal, R. M., and M. T. Lotze. 2000. The dendritic cell and human cancer vaccines. Curr. Opin. Immunol. 12: 583-588.
8. Banchereau, J., B. Schuler-Thurner, A. K. Palucka, and G. Schuler. 2001. Dendritic cells as vectors for therapy. Cell 106: 271-274.
9. Gunzer, M., and S. Grabbe. 2001. Dendritic cells in cancer immunotherapy. Crit. Rev. Immunol. 21: 133-145.
10. Steinman, R. M., and M. Pope. 2002. Exploiting dendritic cells to improve vaccine efficacy. J. Clin. Invest. 109: 1519-1526.
11. Figdor, C. G., I. J. de Vries, W. J. Lesterhuis, and C. J. Melief. 2004. Dendritic cell immunotherapy: mapping the way. Nat. Med. 10: 475-480.
12. Fong, L., D. Brockstedt, C. Benike, L. Wu, and E. G. Engleman. 2001. Dendritic cells injected via different routes induce immunity in cancer patients. J. Immunol. 166: 4254-4259.
13. Mullins, D. W., S. L. Sheasley, R. M. Ream, T. N. Bullock, Y. X. Fu, and V. H. Engelhard. 2003. Roule of immunization with peptide-pulsed dendritic cells controls the distribution of memory and effector T cells in lymphoid tissues and determines the pattern of regional tumor control. J. Exp. Med. 198: 1023-1034.
14. Austyn, J. M., J. W. Kupiec-Weglinski, D. F. Hankins, and P. J. Morris. 1988. Migration patterns of dendritic cells in the mouse: homing to T cell-dependent areas of spleen, and binding within marginal zone. J. Exp. Med. 167: 646-651.
15. Eggert, A. A., M. W. Schreurs, O. C. Boerman, W. J. Oyen, A. J. de Boer, C. J. Punt, C. G. Figdor, and G. J. Adema. 1999. Biodistribution and vaccine efficiency of murine dendritic cells are dependent on the route of administration. Cancer Res. 59: 3340-3345.
16. Ohl, L., M. Mohaupt, N. Czeloth, G. Hintzen, Z. Kiafard, J. Zwirner, T. Blankenstein, G. Henning, and R. Forster. 2004. CCR7 governs skin dendritic cell migration under inflammatory and steady-state conditions. Immunity 21: 279-288.
17. Yoneyama, H., K. Matsuno, and K. Matsushimaa. 2005. Migration of dendritic cells. Int. J. Hematol. 81: 204-207.
18. + T cell priming by dendritic cells in intact lymph nodes. Nat. Immunol. 4: 579-585.
19. Lappin, M. B., J. M. Weiss, V. Delattre, B. Mai, H. Dittmar, C. Maier, K. Manke, S. Grabbe, S. Martin, and J. C. Simon. 1999. Analysis of mouse dendritic cell migration in vivo upon subcutaneous and intravenous injection. Immunology 98: 181-188.
20. Lambert, L. A., G. R. Gibson, M. Maloney, B. Durell, R. J. Noelle, and R. J. Barth, Jr. 2001. Intranodal immunization with tumor lysate-pulsed dendritic cells enhances protective antitumor immunity. Cancer Res. 61: 641-646.
21. + T cell trafficking to inflamed skin: role for tissue microenvironment and dendritic cells in establishment of T cell-homing subsets. J. Immunol. 172: 857-863.
22. Ho, S. N., R. T. Abraham, A. Nilson, B. S. Handwerger, and D. J. McKean. 1987. Interleukin 1-mediated activation of interleukin 4 (IL-4)-producing T lymphocytes: proliferation by IL-4-independent mechanisms. J. Immunol. 139: 1532-1540.
23. + T cells for melanoma immunotherapy in human MHC class I-transgenic mice. J. Immunol. 167: 5824-5831.
24. Overwijk, W. W., A. Tsung, K. R. Irvine, M. R. Parkhurst, T. J. Goletz, K. Tsung, M. W. Carroll, C. Liu, B. Moss, S. A. Rosenberg, and N. P. Restifo. 1998. gp100/pmel 17 is a murine tumor rejection antigen: induction of "self"- reactive, tumoricidal T cells using high-affinity, altered peptide ligand. J. Exp. Med. 188: 277-286.
25. Randolph, G. J., V. Angeli, and M. A. Swartz. 2005. Dendritic-cell trafficking to lymph nodes through lymphatic vessels. Nat. Rev. Immunol. 5: 617-628.
26. Martín-Fontecha, A., S. Sebastiani, U. E. Hopken, M. Uguccioni, M. Lipp, A. Lanzavecchia, and F. Sallusto. 2003. Regulation of dendritic cell migration to the draining lymph node: impact on T lymphocyte traffic and priming. J. Exp. Med. 198: 615-621.
27. McKenna, H. J. 1999. Generating a T cell tumor-specific immune response in vivo: can flt3-ligand-generated dendritic cells tip the balance? Cancer Immunol. Immunother. 48: 281-286.
28. Marroquin, C. E., J. A. Westwood, R. Lapointe, A. Mixon, J. R. Wunderlich, D. Caron, S. A. Rosenberg, and P. Hwu. 2002. Mobilization of dendritic cell precursors in patients with cancer by flt3 ligand allows the generation of higher yields of cultured dendritic cells. J. Immunother. 25: 278-288.
29. Ridolfi, R., A. Riccobon, R. Galassi, G. Giorgetti, M. Petrini, L. Fiammenghi, M. Stefanelli, L. Ridolfi, A. Moretti, G. Migliori, and G. Fiorentini. 2004. Evaluation of in vivo labelled dendritic cell migration in cancer patients. J. Transl. Med. 2: 27.
30. Butcher, E. C., and L. J. Picker. 1996. Lymphocyte homing and homeostasis. Science 272: 60-66.
31. Young, A. J. 1999. The physiology of lymphocyte migration through the single lymph node in vivo. Semin. Immunol. 11: 73-83.
32. Iparraguirre, A., and W. Weninger. 2003. Visualizing T cell migration in vivo. Int. Arch. Allergy Immunol. 132: 277-293.
33. Hugues, S., L. Fetler, L. Bonifaz, J. Helft, F. Amblard, and S. Amigorena. 2004. Distinct T cell dynamics in lymph nodes during the induction of tolerance and immunity. Nat. Immunol. 5: 1235-1242.
34. Masopust, D., V. Vezys, E. J. Usherwood, L. S. Cauley, S. Olson, A. L. Marzo, R. L. Ward, D. L. Woodland, and L. Lefrancois. 2004. Activated primary and memory CD8 T cells migrate to nonlymphoid tissues regardless of site of activation or tissue of origin. J. Immunol. 172: 4875-4882.
35. 1 integrin/VCAM-1, and LFA-1 adhesion pathways. J. Exp. Med. 197: 1255-1267.
36. Nakajima, H., H. Sano, T. Nishimura, S. Yoshida, and I. Iwamoto. 1994. Role of vascular cell adhesion molecule 1/very late activation antigen 4 and intercellular adhesion molecule 1/lymphocyte function-associated antigen 1 interactions in antigen-induced eosinophil and T cell recruitment into the tissue. J. Exp. Med. 179: 1145-1154.
37. 4-integrins and vascular cell adhesion molecule-1. Am. J. Physiol. 272: L219-L229.
38. 4 integrins regulate independent pathways of T lymphocyte recruitment in the pulmonary immune response. J. Immunol. 161: 4396-4403.
39. Bullock, T. N., T. A. Colella, and V. H. Engelhard. 2000. The density of peptides displayed by dendritic cells affects immune responses to human tyrosinase and gp100 in HLA-A2 transgenic mice. J. Immunol. 164: 2354-2361.